That's also true, but only for the learned persons. The general laymen sentiment is that genting still equal casino, which can easily mask ongoing diversification effort, and this carries political risk. From bottomline perspective, casino still constitute a significant portion though.

but I think it is good to diversify outside of Malaysia. The sentiment towards casino business may turn anytime and the licence revoke if political development calls for it.

exactly Cheng. the final marketing authorisation of the drug will be a major catalyst and pave the road for more marketing authorisation in more countries, and hopefully US. But I doubt US FDA will approve it due to political play

There hasn't been any good news for GENT since the pandemic. Cautiously optimistic. While I hope for the good news, the long period of bad news has made believing in the coming of good news less believeable

I predicted last week that the support level last week was due to LKT share purchase and I'm proven correct with the announcement today

Conditional approval is as good as full approval. The latter is quite rare over the history of trend of approval. In condition approval, the company will have to submit further evidence/studies during the period of selling the drug. At that time, it'll be very unlikely that the drug will be pull off the shelf

I believe it is due to support by LKT. Wait for announcements. I may be wrong, I may be able to say "I told you so" haha

how many units of GENT you have and what's your average price Vin? hehe

the broader market will still be affected if US is down just like the last few days

I'm suspecting LKT is waiting for further developments of Trump's tariff announcement before deciding whether/how much to buy back Genting share